Morning Overview on MSN
AI study of protein nanoribbons points to new design rules
Researchers at Pacific Northwest National Laboratory used artificial intelligence to analyze protein nanoribbons, pointing to potential design rules tied to peptide length and secondary structure. The ...
This article and associated images are based on a poster originally authored by Marina Fedorova and Ian Hiles and presented at ELRIG Drug Discovery 2024 in affiliation with GSK. This poster is being ...
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
The Expi293™ PRO Expression System is a high-performance transient HEK293 mammalian protein expression platform designed to help researchers express more proteins faster, at higher yields, and with ...
Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.
Nuclera and leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins
CAMBRIDGE, England & BOSTON & VILLIGEN, Switzerland--(BUSINESS WIRE)--Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results